DDD Stock Recent News

The popular growth investor keeps adding to some of her favorite falling stocks.

ROCK HILL, S.C., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the Food and Drug Administration (FDA) has provided 510(k) clearance for its multi-material, monolithic (one-piece) jetted denture solution. This first-to-market offering comprising two uniquely developed materials — NextDent® Jet Denture Teeth and NextDent® Jet Denture Base — as well as 3D Systems' jetting technology, software and services, enables the production of durable, long-wear, aesthetically beautiful dentures. As a result of implementing the Company's FDA-cleared jetted denture solution, dental laboratories can more efficiently deliver dentures, resulting in an enhanced patient experience.

DDD does not offer a good investment opportunity due to challenging macroeconomic conditions and stiff competition.

ROCK HILL, S.C., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the Food and Drug Administration (FDA) has provided 510(k) clearance for TOTAL ANKLE Patient-Matched Guides to be used with Smith+Nephew's SALTO TALARIS◊ Total Ankle Prosthesis and CADENCE◊ Total Ankle System. The products feature individualized pre-surgical planning and a patient-specific 3D-printed instrument set that ensures accurate implant alignment and sizing for tailored total ankle replacement surgery. The collaboration between 3D Systems and Smith+Nephew, the global medical technology company, achieved these patient-matched solutions that enable surgeons to prepare the bony anatomy of the tibia and talus for placement of implants intended to restore proper function of the ankle joint. These patient-matched guides are engineered and manufactured using 3D Systems'  VSP ® surgical planning solutions  that combine best-in-class digital workflows with the industry's broadest additive

ROCK HILL, S.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD), announced QuickCast Air™ - an advanced tool in its investment casting portfolio, designed to maximize material removal from the interior of casting patterns. This enables reduced material consumption, lower pattern costs, faster build times, cleaner burnout processes, and improved draining efficiency. As a result, end-users in industries such as foundries, aerospace & defense, and energy can reliably deliver large, high-precision investment casting patterns at a fraction of the time and cost of traditional tooling and with no limitation on geometric complexity. QuickCast Air is already helping some of the Company's large-volume aerospace customers reduce the material consumption on their patterns by up to 50%. Additionally, customers are seeing a multi-hour reduction in build times.

The 3D printing specialist saw a double-digit fall in quarterly revenue. This was due largely to one client, however.

Stratasys reported declining sales and a big GAAP loss yesterday. Today, its rival in 3D printing, 3D Systems, reported pretty much the same thing.

3D Systems Corporation (NYSE:DDD ) Q2 2024 Earnings Conference Call August 29, 2024 5:00 PM ET Company Participants Mick McCloskey - Vice President, Investor Relations Jeffrey Graves - President & Chief Executive Officer Jeff Creech - Executive Vice President & Chief Financial Officer Conference Call Participants Troy Jensen - Cantor Fitzgerald Danny Eggerichs - Craig-Hallum Jim Ricchiuti - Needham & Company Ananda Baruah - Loop Capital Markets Operator Hello, and welcome to the 3D Systems First Half 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.

3D Systems (DDD) first-quarter 2024 top-line growth suffers from challenging macroeconomic conditions.

Investing in 3D bioprinting stocks is a highly speculative and specialized approach to the biotech industry in general. That's because it blends two relatively niche technologies to create a broader application that may be part of the future of surgery and medical treatments.